| Literature DB >> 35878174 |
Yu-Kai Huang1,2,3, Yen-Chia Chen4,5,6, Chia-Chun Liu7, Hui-Chun Cheng7, Anthony T Tu8, Kun-Che Chang1,7,9.
Abstract
There are an estimated 5.4 million snakebite cases every year. People with snakebite envenoming suffer from severe complications, or even death. Although some review articles cover several topics of snakebite envenoming, a review of the cases regarding cerebral complications, especially rare syndromes, is lacking. Here, we overview 35 cases of snakebite by front-fanged snakes, including Bothrops, Daboia, Cerastes, Deinagkistrodon, Trimeresurus, and Crotalus in the Viperidae family; Bungarus and Naja in the Elapidae family, and Homoroselaps (rare cases) in the Lamprophiidae family. We also review three rare cases of snakebite by rear-fanged snakes, including Oxybelis and Leptodeira in the Colubridae family. In the cases of viper bites, most patients (17/24) were diagnosed with ischemic stroke and intracranial hemorrhage, leading to six deaths. We then discuss the potential underlying molecular mechanisms that cause these complications. In cases of elapid bites, neural, cardiac, and ophthalmic disorders are the main complications. Due to the small amount of venom injection and the inability to deep bite, all the rear-fanged snakebites did not develop any severe complications. To date, antivenom (AV) is the most effective therapy for snakebite envenoming. In the six cases of viper and elapid bites that did not receive AV, three cases (two by viper and one by elapid) resulted in death. This indicates that AV treatment is the key to survival after a venomous snakebite. Lastly, we also discuss several studies of therapeutic agents against snakebite-envenoming-induced complications, which could be potential adjuvants along with AV treatment. This article organizes the diagnosis of hemotoxic and neurotoxic envenoming, which may help ER doctors determine the treatment for unidentified snakebite.Entities:
Keywords: anti-venom serum; hemotoxin; intracranial hemorrhage; ischemic stroke; neurotoxin; snakebite envenoming
Mesh:
Substances:
Year: 2022 PMID: 35878174 PMCID: PMC9320586 DOI: 10.3390/toxins14070436
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 5.075
Brain and nervous-system complications following Viperidae envenoming.
| Complications | Snake Species | Sex/Age | Bite Mark | Other Symptoms | Presuming Venom | Outcome | Antivenom/Amount | Ref. |
|---|---|---|---|---|---|---|---|---|
|
| M/74 | Elbow | Atrial fibrillation | Dead | IV Antivenom/80 mL | [ | ||
|
| F/49 | Foot | Speech disturbances | Recovered | IV Antivenom/3 vials | [ | ||
|
| M/52 | Foot | Sudden loss of consciousness | SVMPs, Hemotoxin | Recovered | IV Antivenom/Unclear | [ | |
|
| F/59 | Foot | Hypothermia, Bradycardia and Hypotension | Dead | IV Antivenom/80 mL | [ | ||
|
| M/54 | Hand | Facial fasciculations | Dead | IV Antivenom/16 vials | [ | ||
|
| Unidentified species | F/48 | Hand | Exotropia | Recover with minor visual complication | IV Antivenom/Unclear | [ | |
|
|
| M/50 | Foot | Severe pain | Recovered | IV Antivenom/1 vial | [ |
ADEM: Acute demyelinating encephalomyelitis; AHL: Acute hemorrhagic leukoencephalitis; SVMPs: Snake-venom metalloproteinases; PLA: Phospholipase A2.
Brain and nervous-system complications following Elapidae envenoming.
| Complications | Snake Species | Sex/Age | Bite Mark | Other Symptoms | Presuming Venom Components | Outcome | Antivenom/Amount | Ref. |
|---|---|---|---|---|---|---|---|---|
|
| M/35 | Hand | Tachycardia, prolonged micturition | Neurotoxin, | Permanent mydriasis | IV Antivenom/6 vials | [ | |
|
| M/41 | Hand | Tachycardia | Permanent mydriasis | IV Antivenom/3 vials | |||
|
| F/12 | Hand | Periodic convulsions | Permanent brain damage | Unclear | |||
|
| F/17 | Foot | Seizure | Neurotoxin | Dead |
| [ | |
|
| M/15 | Foot | Paraplegia | Neurotoxin | Loss of vision | IV Antivenom/1 vial | [ | |
|
| M/10 | Ear | Hypertension | Neurotoxin | Recovered with vision blurring | IV Antivenom/10 vials | [ | |
|
| M/38 |
| Difficulty in swallowing and double vision | Neurotoxin | Recovered | IV Antivenom/9 vials | [ | |
|
| F/27 |
| Mydriasis | Recovered | IV Antivenom/Unclear | |||
|
| F/57 | Hand | Breathing ceased | Neurotoxin | Recovered | IV Antivenom/50 vials | [ |
EMNS: Early-morning neuroparalytic syndrome; N/A: Not Applied; N/K: Not known; PLA: Phospholipase A2; PRES: Posterior reversible encephalopathy syndrome.
Brain and nervous-system complications following Viperidae and Lamprophiidae bite: both hemotoxic and neurotoxic venoms.
| Complications | Snake Species | Sex/Age | Bite Mark | Other Symptoms | Presuming Venom | Outcome | Antivenom/Amount | Ref. |
|---|---|---|---|---|---|---|---|---|
|
| M/18 | Foot | Sever pain | Hemotoxin | Recovered with minor complications | IV Antivenom/6 vials | [ | |
|
| F/40 | Foot | Hypotonia of the limbs | Significant ataxia of gait | IV Antivenom/24 vials | [ | ||
|
| M/70 | Foot | Ptosis, Seizure | Hemotoxin, Neurotoxin | Recovered | IV Antivenom/20 vials | [ | |
|
| M/55 | Foot | Ptosis, Speech disturbances | Hemotoxin, Neurotoxin | Recovered | IV Antivenom/35 vials | ||
|
| F/5 | Foot | Thrombocytopenia, Acute anemia | SVMPs, Hemotoxin, | Dead |
| [ | |
|
| M/55 | Foot |
| Recovered | IV Antivenom/26 vials | [ | ||
|
| F/27 | Foot | Gerstmann’s syndrome | Hemotoxin, Neurotoxin | Recovered | IV Antivenom/Unclear | [ | |
|
| M/50 | Foot | Status epilepticus | Motor deficit |
| [ | ||
|
| M/43 | Foot | Ptosis and ophthalmoplegia | Dead | IV Antivenom/35 vials | [ | ||
|
| F/32 | Hand | Tonic-clonic seizures | Dead |
| [ | ||
|
| M/51 | Foot | Hemodynamic shock | Recovered |
| |||
|
| M/36 | Foot | Hematemesis and gum bleeding | SVMPs, Hemotoxin | Recovered | IV Antivenom/30 vials | [ | |
|
| M/44 | Foot | Hemorrhagic necrosis | Recovered |
| [ | ||
|
| F/23 | Foot | Reduction in visual acuity | SVMPs, Hemotoxin, | Recovered with visual impairment | IV Antivenom/Unclear | [ | |
|
|
| M/46 | Hand | Pain, swelling, and erythema of his left hand | Hemotoxin, Neurotoxin | Recovered | IV Antivenom/20 vials | [ |
|
|
| W/32 | Hand | Somnolent, febrile, suffering of headache, tachypnoea | Hemotoxin, Neurotoxin | Recovered with complications |
| [ |
|
| Crotalus cerastes (sidewinder rattlesnake) | M/56 | Foot | Burning and tingling pain | Hemotoxin, Neurotoxin | Recovered |
| [ |
|
| M/Adult | Palm | Slight burning sensation, swelling | Recovered |
| [ | ||
|
| M/Adult | Thumb | Swelling | Recovered |
|
ADEM: Acute demyelinating encephalomyelitis; AHL: Acute hemorrhagic leukoencephalitis; SVMPs: Snake-venom metalloproteinases; N/A: Not Applied; N/K: Not known; PLA: Phospholipase A2; PRES: Posterior reversible encephalopathy syndrome.
Complications following rear-fanged Colubridae envenoming.
| Complications | Snake Species | Sex/Age | Bite Mark | Other Symptoms | Presuming Venom | Outcome | Antivenom | Ref. |
|---|---|---|---|---|---|---|---|---|
|
| M/67 | Arm | Moderate pain, tachycardiac, local bleeding | Hemotoxin, | Recovered |
| [ | |
|
| F/29 | Hand | Burning sensation and itching, pain | Recovered |
| [ | ||
|
| M/44 | Arm | Fever, chills, nausea, and light-headedness. | SVMPs, Hemotoxin, | Recovered |
| [ |
CRPS: Complex regional pain syndrome; PLA: Phospholipase A2; SVMPs: Snake-venom metalloproteinases; 3FTx: Three-finger toxins, N/A: Not Applied.
Figure 1Main cerebral complications of snakebite envenoming, ischemic stroke, and cerebral hemorrhage.
Figure 2Presumed mechanisms for cerebral complications following snakebite envenoming. SVMPs: Snake-venom metalloproteinases; SVSPs: Snake-venom serine proteases; PLA: Phospholipase A2; LAAOs: L-amino-acid oxidase; Snaclecs: Snake C-type lectin-like proteins; N/A: Not applied. The figure is adapted from the previously described [75].